How is wound progression monitored clinically after a modality-based intervention?

• A. By assessing wound size, depth, granulation tissue, exudate, and signs of infection
• B. By evaluating only the wound color
• C. By relying solely on imaging
• D. By assessing wound size, depth, granulation tissue, exudate, signs of infection, plus patient-reported pain

Answer: (D)

Monitoring wound progression after modality-based interventions relies on a comprehensive, ongoing assessment that combines objective measurements with patient input. Objectively, you track changes in wound size and depth to see contraction and closure, and you observe the wound bed for tissue type—healthy granulation tissue indicates progress, while necrotic tissue or slough signals the need for debridement or a change in care. Exudate tells you about drainage and inflammation, including its amount and consistency, and you examine the periwound skin for signs of irritation or edema. Signs of infection—such as redness spreading beyond the wound margins, warmth, increasing edema, foul odor, purulent drainage, or systemic symptoms—require prompt attention and possible therapy adjustments. Equally important is the patient’s report of pain, which provides insight into tissue response, comfort, and tolerance to the modality, guiding dosing and pacing of interventions. Relying on any single measure—color alone, imaging alone, or excluding patient input—can miss meaningful changes, whereas a combined assessment gives a complete picture of healing progress and helps tailor the treatment plan.